IP Library Granted Patent US 12,343,696
Granted Patent B2
US 12,343,696 · App. 17/727,857 · Granted Jul 1, 2025

Capsules

Inventors: Mariana B T Cardoso (Ixelles, BE); Andre Martim Barros (Woluwe Saint Etienne, BE); Peter De Nies (Antwerp, BE); Pierre Daniel Verstraete (Lambert, BE); Valerie Wong (Mason, OH); Steven Daryl Smith (Fairfield, OH); Johan Smets (Lubbeek, BE)
Assignee: The Procter & Gamble Company
B01J13/06C11B9/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,696
App. No.
17/727,857
Granted
Jul 1, 2025
Kind
B2
Abstract

A population of capsules, the capsules can include a core including a benefit agent and a shell surrounding the core, wherein the shell can include a first shell component.

Claims (42)

1. A populations of capsules, the capsules comprising:

an aqueous core comprising a benefit agent; and

a shell surrounding the core, the shell comprising

a substantially inorganic first shell component comprising:

a condensed layer comprising a condensation product of a precursor, and

a nanoparticle layer comprising inorganic nanoparticles,

wherein the precursor comprises at least one compound of Formula (I),

(M v O z Y n ) w   (Formula I)

where M is one or more of silicon, titanium and aluminum,

v is the valence number of M and is 3 or 4,

z is from 0.5 to 1.6

each Y is independently selected from —OH, —OR 2 , halo,

 —NH 2 , —NHR 2 , —N(R 2 ) 2 , and

wherein R 2 is a C 1 to C 20 alkyl, C 1 to C 20 alkylene, C 6 to C 22 aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S,

R 3 is a H, C 1 to C 20 alkyl, C 1 to C 20 alkylene, C 6 to C 22 aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S,

n is from 0.7 to (v−1), and

w is from 2 to 2000, and wherein the mass % of condensed layer with respect to the total mass of the shell is from about 10% to about 99;

wherein the inorganic nanoparticles of the first shell component comprise at least one of SiO 2 , TiO 2 , Al 2 O 3 , Fe 2 O 3 , Fe 3 O 4 , CaCo 3 , clay, silver, gold, or copper.

2. The capsules of claim 1 , wherein the shell further comprises an inorganic second shell component surrounding the first shell component.

3. The capsules of claim 1 , wherein the inorganic second shell component comprises at least one of SiO 2 , TiO 2 , Al 2 O 3 , CaCO 3 , Ca 2 SiO 4 , Fe 2 O 3 , Fe 3 O 4 , iron, silver, nickel, gold, copper, or clay.

4. The capsules of claim 1 , wherein the benefit agent comprises at least one of perfume raw materials, perfume compositions, skin coolants, vitamins, sunscreens, antioxidants, glycerin, bleach encapsulates, chelating agents, antistatic agents, insect and moth repelling agents, colorants, antioxidants, sanitization agents, disinfecting agents, germ control agents, mold control agents, mildew control agents, antiviral agents, drying agents, stain resistance agents, soil release agents, chlorine bleach odor control agents, dye fixatives, dye transfer inhibitors, color maintenance agents, optical brighteners, color restoration/rejuvenation agents, anti-fading agents, whiteness enhancers, anti-abrasion agents, wear resistance agents, fabric integrity agents, anti-wear agents, anti-pilling agents, defoamers, anti- foaming agents, UV protection agents, sun fade inhibitors, anti-allergenic agents, enzymes, water proofing agents, fabric comfort agents, shrinkage resistance agents, stretch resistance agents, stretch recovery agents, skin care agents, and natural actives, antibacterial actives, antiperspirant actives, cationic polymers, dyes, metal catalysts, non-metal catalysts, activators, pre-formed peroxy carboxylic acids, diacyl peroxides, hydrogen peroxide sources, or enzymes.

5. The capsules of claim 1 , wherein the compound of formula (I) has a Polystyrene equivalent Weight Average Molecular Weight (Mw) of from about 700 Da to about 30,000 Da.

6. The capsules of claim 5 , wherein the compound of formula (I) has a degree of branching of 0.2 to about 0.6.

7. The capsules of claim 1 , wherein the compound of formula (I) has a molecular weight polydispersity index of about 1 to about 20.

8. The capsules of claim 1 , wherein the precursor comprises at least one compound of Formula (II),

(M v O z Y n R 1 p ) w   (Formula II)

where M is one or more of silicon, titanium and aluminum,

v is the valence number of M and is 3 or 4,

z is from 0.5 to 1.6,

each Y is independently selected from —OH, —OR 2 , halo

—NH 2 , —NHR 2 , —N(R 2 ) 2 , and

wherein R 2 is a C 1 to C 20 alkyl, C 1 to C 20 alkylene, C 6 to C 22 aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S,

R 3 is a H, C 1 to C 20 alkyl, C 1 to C 20 alkylene, C 6 to C 22 aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S,

n is from 0 to (v−1),

each R 1 is independently selected from a C 1 to C 30 alkyl, a C 1 to C 30 alkylene, a C 1 to C 30 alkyl substituted with one or more of a halogen, —OCF 3 , —NO 2 , —CN, —NC, —OH, —OCN, —NCO, alkoxy, epoxy, amino, mercapto, acryloyl, CO 2 H, CO 2 alkyl, aryl, and heteroaryl, and a C 1 to C 30 alkylene substituted with one or more of a halogen, —OCF 3 , —NO 2 , —CN, —NC, —OH, —OCN, —NCO, alkoxy, epoxy, amino, mercapto, acryloyl, CO 2 H, CO 2 alkyl, aryl, and heteroaryl,

p is present in an amount up to pmax, and

w is from 2 to 2000;

wherein pmax=60/[9*Mw(R 1 )+8], where Mw(R 1 ) is the molecular weight of the R 1 group.

9. The capsules of claim 8 , wherein the shell further comprises an inorganic second shell component surrounding the first shell component.

10. The capsules of claim 8 , wherein the compound of formula (II) has a Polystyrene equivalent Weight Average Molecular Weight (Mw) of from about 700 Da to about 30,000 Da.

11. The capsules of claim 8 , wherein the compound of formula (II) has a molecular weight polydispersity index of from about 1 to about 20.

12. The capsules of claim 11 , wherein the compound of formula (II) has a degree of branching of from about 0.2 to about 0.6.

Continuity (4)
Continuation 16851176 · Apr 17, 2020
Provisional Application 62913192 · Oct 10, 2019
Provisional Application 62835013 · Apr 17, 2019
Related Publication 20220258118A1 · Aug 18, 2022
References Cited (121)
US 5500223A · Behan et al. · 1996 [cited by applicant]
US 6243909B1 · Graham et al. · 2001 [cited by applicant]
US 6537583B1 · Dupuis et al. · 2003 [cited by applicant]
US 8425940B2 · Lapidot et al. · 2013 [cited by applicant]
US 8931971B2 · Schwarz et al. · 2015 [cited by applicant]
US 9192548B2 · Traynor · 2015 [cited by applicant]
US 9603784B2 · Shimizu et al. · 2017 [cited by applicant]
US 10046291B2 · Yamazaki · 2018 [cited by applicant]
US 10285928B2 · Marsh et al. · 2019 [cited by applicant]
US 11904287B2 · Cardoso · 2024 [cited by examiner]
US 11912961B2 · Barros · 2024 [cited by examiner]
US 11938349B2 · Cetti · 2024 [cited by examiner]
US 12077728B2 · Barros · 2024 [cited by examiner]
US 20040163674A1 · Policicchio et al. · 2004 [cited by applicant]
US 20050158369A1 · Dorschner et al. · 2005 [cited by applicant]
US 20060188551A1 · Hauser et al. · 2006 [cited by applicant]
US 20070082033A1 · Doerschner et al. · 2007 [cited by applicant]
US 20080096780A1 · Veugelers et al. · 2008 [cited by applicant]
US 20090247449A1 · Burdis · 2009 [cited by applicant]
US 20100143422A1 · Popplewell et al. · 2010 [cited by applicant]
US 20100247660A1 · Lei · 2010 [cited by examiner]
US 20110094416A1 · Kawai · 2011 [cited by applicant]
US 20110104221A1 · Galeone et al. · 2011 [cited by applicant]
US 20110118161A1 · Looft · 2011 [cited by applicant]
US 20110152159A1 · Labeque · 2011 [cited by applicant]
US 20110177951A1 · Toledano · 2011 [cited by applicant]
US 20120104639A1 · Traynor et al. · 2012 [cited by applicant]
US 20120128747A1 · Veronique et al. · 2012 [cited by applicant]
US 20120202695A1 · Toledano · 2012 [cited by applicant]
US 20120237578A1 · Lei · 2012 [cited by applicant]
US 20120256336A1 · Yano · 2012 [cited by applicant]
US 20130040817A1 · Dreher · 2013 [cited by applicant]
US 20140044761A1 · Lei et al. · 2014 [cited by applicant]
US 20140331414A1 · Bone · 2014 [cited by applicant]
US 20140338134A1 · Fernandez Prieto et al. · 2014 [cited by applicant]
US 20140342972A1 · Smets · 2014 [cited by applicant]
US 20160168509A1 · Hitchcock · 2016 [cited by applicant]
US 20160168510A1 · Tasker et al. · 2016 [cited by applicant]
US 20160168511A1 · Hitchcock et al. · 2016 [cited by applicant]
US 20160184196A1 · Baxter et al. · 2016 [cited by applicant]
US 20160303531A1 · Yamazaki · 2016 [cited by applicant]
US 20160317993A1 · Rotello et al. · 2016 [cited by applicant]
US 20170073237A1 · Lim · 2017 [cited by applicant]
US 20170349865A1 · Zerhusen et al. · 2017 [cited by applicant]
US 20180085291A1 · Sasaki · 2018 [cited by applicant]
US 20180207451A1 · Toledano · 2018 [cited by applicant]
US 20180339176A1 · Toledano · 2018 [cited by applicant]
US 20190143266A1 · Dale · 2019 [cited by applicant]
US 20200114328A1 · Jerri et al. · 2020 [cited by applicant]
US 20200129947A1 · Ouali et al. · 2020 [cited by applicant]
US 20200255776A1 · Schmiedel et al. · 2020 [cited by applicant]
US 20200330948A1 · Cardoso et al. · 2020 [cited by applicant]
US 20200330949A1 · Cardoso et al. · 2020 [cited by applicant]
US 20200330950A1 · Cardoso et al. · 2020 [cited by applicant]
US 20220118287A1 · Cetti et al. · 2022 [cited by applicant]
US 20220118417A1 · Smith et al. · 2022 [cited by applicant]
US 20220119740A1 · Barros et al. · 2022 [cited by applicant]
US 20220119741A1 · Smets et al. · 2022 [cited by applicant]
US 20220119742A1 · Smets et al. · 2022 [cited by applicant]
US 20220119743A1 · Barros et al. · 2022 [cited by applicant]
US 20220119745A1 · Barros et al. · 2022 [cited by applicant]
US 20240060003A1 · Lynch · 2024 [cited by applicant]
US 20240060012A1 · Lynch · 2024 [cited by applicant]
CA 2980792A1 · 2010 [cited by applicant]
CN 103432970A · 2013 [cited by applicant]
CN 105612248A · 2016 [cited by applicant]
CN 105734540A · 2016 [cited by applicant]
CN 107001979A · 2017 [cited by applicant]
CN 107249545B · 2021 [cited by applicant]
EP 1767613A1 · 2007 [cited by applicant]
EP 1767614A1 · 2007 [cited by applicant]
EP 2078696A1 · 2009 [cited by applicant]
EP 3181674A1 · 2017 [cited by applicant]
EP 2865423B1 · 2020 [cited by applicant]
JP 2010209132A · 2010 [cited by applicant]
JP 2010215806A · 2010 [cited by applicant]
JP 2012207067A · 2012 [cited by applicant]
WO 0145615A1 · 2001 [cited by applicant]
WO 2005044220A1 · 2005 [cited by applicant]
WO 2007019201A1 · 2007 [cited by applicant]
WO 2009106318A2 · 2009 [cited by applicant]
WO 2011154421A1 · 2011 [cited by applicant]
WO 2013078551A1 · 2013 [cited by applicant]
WO 2013083760A2 · 2013 [cited by applicant]
WO 2013174921A1 · 2013 [cited by applicant]
WO 2016100477A1 · 2016 [cited by applicant]
WO 2016100479A1 · 2016 [cited by applicant]
WO 2017016636A1 · 2017 [cited by applicant]
WO 2017075074A1 · 2017 [cited by applicant]
WO WO2017161364A1 · 2017 [cited by examiner]
WO 2018189588A1 · 2018 [cited by applicant]
WO 2018231886A1 · 2018 [cited by applicant]
WO 2019108713A1 · 2019 [cited by applicant]
WO 2019108718A1 · 2019 [cited by applicant]
WO 2020077451A1 · 2020 [cited by applicant]
WO 2020214876A1 · 2020 [cited by applicant]
WO 2020214877A1 · 2020 [cited by applicant]
WO 2020214878A1 · 2020 [cited by applicant]
All Office Actions; U.S. Appl. No. 18/410,116, filed Jan. 11, 2024. [cited by applicant]
All Office Actions; U.S. Appl. No. 18/418,649, filed Jan. 22, 2024. [cited by applicant]
Unpublished U.S. Appl. No. 18/410,116, filed Jan. 11, 2024, to Mariana B. T. Cardoso et al. [cited by applicant]
Unpublished U.S. Appl. No. 18/418,649, filed Jan. 22, 2024, to Andre Martim Barros et al. [cited by applicant]
All Office Actions; U.S. Appl. No. 18/581,755, filed Feb. 20, 2024. [cited by applicant]
Unpublished U.S. Appl. No. 18/581,755, filed Feb. 20, 2024, to Jonathan Robert Cetti et al. [cited by applicant]
All Office Actions; U.S. Appl. No. 18/115,890, filed Mar. 1, 2023. [cited by applicant]
Unpublished U.S. Appl. No. 18/115,890, filed Mar. 1, 2023, to Mariana B T Cardoso et al. [cited by applicant]
15508 PCT Search Report and Written Opinion for PCT/US2020/028621; dated Jul. 7, 2020, 13 pages. [cited by applicant]
All Office Actions; U.S. Appl. No. 16/851,176, filed Apr. 17, 2020. [cited by applicant]
All Office Actions; U.S. Appl. No. 16/851,194, filed Apr. 17, 2020. [cited by applicant]
All Office Actions; U.S. Appl. No. 16/851,173, filed Apr. 17, 2020. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/498,016, filed Oct. 11, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/500,970, filed Oct. 14, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/500,979, filed Oct. 14, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/500,984, filed Oct. 14, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/501,202, filed Oct. 14, 2021. [cited by applicant]
European Search Report and Written Opinion for EP 19169894, dated Dec. 17, 2019, 12 pages. [cited by applicant]
Jyothi et al., “Microencapsulation techniques, factors influencing encapsulation efficiency”, Journal of Microencapsulation, 27:3, pp. 187-197. [cited by applicant]
Liu, M.: “Understanding the mechanicalstrength of micro capsules and their adhesion on fabric surfaces”,2010, University of Birmingham,XP055511234, cited in the application pp. 86-89 p. 104-p. 106 p. 118. [cited by applicant]
Thompson et al., “Colloidosomes: Synthesis, properties and applications”, Journal of Colloid and Interface Science, 447, 2015, pp. 217-228. [cited by applicant]
All Office Actions: U.S. Appl. No. 18/894,382, filed Sep. 24, 2024. [cited by applicant]
Unpublished U.S. Appl. No. 18/894,382, filed Sep. 24, 2024, Andre Martim Barros et al. [cited by applicant]